Skip to content

Online CBT-I for High Blood Pressure

Online CBT-I for High Blood Pressure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02299193
Enrollment
58
Registered
2014-11-24
Start date
2014-08-31
Completion date
2016-08-31
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Insomnia, Prehypertension

Keywords

cognitive behavioral therapy for insomnia, sleep hygiene

Brief summary

The purpose of this study is to compare the effect of 6-weekly, 20 minute sessions of 2 online behavioral sleep interventions (cognitive behavioral therapy or healthy sleep habits) on blood pressure, sleep, depressive symptoms and anxiety in people with insomnia and prehypertension or hypertension.

Detailed description

Approximately 30% of US adults have prehypertension (untreated blood pressure ≥120-139/80-89 mmHg) and 29% have hypertension (blood pressure ≥ 140/90 mmHg or antihypertensive medication use). Numerous factors contribute to the development of prehypertension and hypertension including age, genetics, obesity, and behavioral factors such as exercise and diet.However, the sleep disorder insomnia is another behavioral factor increasingly implicated with risk of hypertension. Insomnia, the most frequent sleep complaint in adults, is characterized by difficulty falling asleep, trouble maintaining sleep or non-restorative sleep coupled with significant daytime distress or functional impairment. Insomnia is a pervasive sleep disorder associated with decreased quality of life, reduced work productivity, and increased health care costs; it is increasingly identified as a cardiovascular disease risk factor. Lifestyle modifications recommended for pre-hypertension and hypertension do not address sleep. This pilot randomized clinical trial will test the preliminary efficacy of an online cognitive behavioral therapy intervention (N=40) versus an online healthy sleep habits intervention (N=20), to reduce blood pressure in a sample of untreated individuals with insomnia and prehypertension or hypertension. Participants will be followed for 12-weeks post-intervention. Primary outcome measures are systolic blood pressure. Secondary measures include sleep efficiency, insomnia severity, physical and mental function.

Interventions

BEHAVIORALCognitive Behavioral Therapy

6 weekly, 20 minute online sessions about how thoughts and behaviors can affect sleep

BEHAVIORALHealthy Sleep Habits

6 weekly, 20 minute online sessions about healthy sleep practices

Sponsors

American Heart Association
CollaboratorOTHER
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* prehypertension or hypertension, insomnia (difficulty getting to sleep, staying asleep and/or early morning awakenings), internet access, current email use, willingness to be randomized to either intervention group, ability to read/write in English.

Exclusion criteria

* medication known to alter sleep, sleep disorder (other than insomnia), frequent travel over 2-3 time zones, currently receiving behavioral treatment for insomnia, major depression, anxiety disorders, PTSD or bipolar disorder, \>14 alcoholic drinks/week, recreational drug use, prior diagnosis of: epilepsy, dementia/Alzheimer's disease, renal failure requiring dialysis, stroke, secondary hypertension, angina, peripheral artery disease, heart failure, myocardial infarction or cardiac surgery within the past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Systolic Blood Pressure8 and 20 weeksSystolic blood pressure will be measured at baseline, 8 and 20 weeks

Secondary

MeasureTime frameDescription
Change in Insomnia Severity Index8 and 20 weeksInsomnia Severity Index (ISI) questionnaire will be measured at baseline, 8 and 20 weeks
Changes in Sleep Efficiency8 and 20 weeksActigraphy based sleep efficiency will be measured at baseline, 8 and 20 weeks
Change in Depressive Symptoms8 and 20 weeksDepressive symptoms measured at baseline, 8 and 20 weeks
Change in mental functioning8 and 20 weeksMental function measured at baseline, 8 and 20 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026